Placeholder Image

字幕表 動画を再生する

  • now the United Kingdom will not escape the effects of a third wave of the pandemic, given the sharp rise in cases in parts of the European Union.


  • That's the warning from the Prime Minister, Boris Johnson, who said that people should be under no illusion about the dangers.


  • One minister also warned that the UK might put all our European neighbors on the red list of countries where arrivals are either banned or put into quarantine hotels during the day.


  • The row between the UK and the EU over vaccine supplies has intensified with the threat that the EU could block doses of vaccines which are manufactured in the EU from being exported to the UK Our political editor Laura Coons Berg, has more details.

    ワクチンの供給をめぐる英国とEUの対立が激化し、EUで製造されたワクチンの英国への輸出をEUが阻止する可能性が出てきました。 政治担当のローラ・クーンズ・バーグが詳細をお伝えします。

  • France Tonight Quiet Paris Back in lockdown, the disease double where it was last week.

    France Tonight Quiet Paris 監禁状態に戻る、病気は先週の倍。

  • On one side of the channel, the number of cases higher and higher take up of the vaccine stubbornly low, but on the other, the opposite the disease falling back and vaccines rising, you can see sadly there is a third wave underway when a wave hits.


  • Our friends, I'm afraid, washes up on our shores as well and I expect that we will.


  • We will feel those effects in in due course.


  • That's why we're getting on with our vaccination program as as fast as we can, much quicker here than on the continent where countries are closing their doors again.


  • But they've been public doubts from politicians about the safety of the jabs and significant shortfalls in the AstraZeneca vaccines the EU ordered.


  • And in the last few days, Brussels has dangled the prospect of blocking exports.


  • Nothing is off the table.


  • It is entirely legitimate for the European Union to be looking at the different tools that it has at its disposal or could have at its disposal.


  • Getting the vaccine here isn't always smooth war straightforward, but a big majority of the 100 million AstraZeneca jabs on order are being made in the U.


  • K A small amounts due from a factory in the Netherlands, and there are suggestions that could be shared with the EU.

    K オランダの工場からは少量ですが、EUと共有できるような提案があります。

  • 10 million doses are expected from India, five already here and five held up, but there are 40 million of the fighter job on order.


  • It's mainly made in Belgium but relies on a component made here first off there's no immediate threat to the vaccine program here.


  • The government's adamant contracts, signed months ago, will be honored.


  • And although Boris Johnson's talked on the phone to EU leaders, there's no desire in Downing Street to get sucked into a diplomatic screaming match.


  • But the EU is so far behind they are likely to keep pushing hard for a way to catch up.


  • But many of its members might resist something as blunt or dramatic a stopping vaccines crossing the channel.


  • I think it would be a very retrograde step.


  • It would, in my view, be counterproductive.


  • I understand the issues with AstraZeneca.


  • There's huge tension there between AstraZeneca and the European Union.


  • They have not fulfilled their contracts, but there is no point in undermining the other companies.


  • While vaccinations break records here, a brand new center in Middlesbrough can give 1000 injections a day.


  • Travel to our neighbors could be limited even further.


  • In this pandemic, vaccines have a high practical and political price.


  • Laura Ginsberg, BBC News Westminster Well European leaders will be meeting on Thursday to discuss this and other issues.

    Laura Ginsberg, BBC News Westminster さて、欧州の首脳陣は木曜日にこの問題やその他の問題を議論するために会合を開きます。

  • Let's go live to Brussels and talk to our Europe editor Katia Adler, controls over vaccine exports.


  • Katia.


  • How likely are they?


  • Well here it's important to realize that EU leaders are under growing pressure to do something about vaccines.


  • For weeks, citizens across the EU have been looking at the very successful vaccine rollout in the UK and they're asking, Well, what about our vaccines?


  • This at a time when there is a third wave of the virus that's sweeping across much of mainland Europe.


  • So, of course, the vaccine debate is now bled international politics, with some EU leaders feeling that their government's credibility is on the line here, definitely the credibility of the European Commission.


  • But that said, EU diplomats that I've been talking to today say the focus of EU leaders when they meet at their summit on Thursday will be how to secure more vaccines for the EU and the different methods possible to do that rather than an obsessive focus on vaccine export bans.


  • And that's because, as we heard their in laws report, you leaders are divided about the ideas of bands that even divided about the idea of using existing powers.


  • They have more vaccine export controls.


  • They've only been used once to date to stop vaccine exports leaving the EU.


  • There is an appreciation here that in order to manufacture vaccines, you have this very delicate global supply chain that a lot of leaders are worried about disturbing.


  • So, yes, you they well will be talking about possible export bans on Thursday.


  • But it's unlikely they're going to come to a definitive unanimous conclusion.


  • Many thanks again catch Adler, therefore US in Brussels.


  • Let's stay with this story because results from a trial in the United States have again confirmed that the Oxford AstraZeneca vaccine is both safe and effective.


  • Let's talk to our medical editor, Fergus Walsh was with us.


  • What do the results say?


  • Focus impressive results, which paved the way for the Oxford AstraZeneca vaccine to be finally approved in the US, which was waiting on its own domestic trial data.


  • There were more than 32,000 volunteers on the trial, mostly in the U.


  • S.


  • But also Chile and Peru.


  • Now the vaccine was 79% effective at preventing symptomatic illness, but it was 100% 100% effective at stopping severe disease keeping people out of hospital.


  • And that was after two doses of the vaccine space four weeks apart.


  • Crucially, there were no safety concerns such as blood clots, and the vaccine was as effective in older adults as it was in younger adults.


  • Now, both those points will be important for EU nations, which some of whom are still not using the jab because of fear over clots.


  • And countries like France, which initially wouldn't use the vaccine in older adults and now will only use the vaccine in the over 55 now.


  • There's no wonder there's further erosion in public confidence in the vaccine in the EU.


  • But these results confirmed the real world data.


  • Hundreds of thousands of people a day in the UK are having this vaccine.


  • And like the fighter jab, it's having a massive impact cutting deaths and protecting people from Covid Fergus.


now the United Kingdom will not escape the effects of a third wave of the pandemic, given the sharp rise in cases in parts of the European Union.



動画の操作 ここで「動画」の調整と「字幕」の表示を設定することができます

B1 中級 日本語 ワクチン eu 輸出 アストラ 首脳 製造

ボリス・ジョンソン氏、英国はコビッド・パンデミックの第3波から逃れられないと発言 - BBCニュース (Boris Johnson says UK will not escape third wave of Covid pandemic - BBC News)

  • 0 0
    林宜悉 に公開 2021 年 03 月 23 日